Holen Sie sich die Stockscreener-App
2.47
2.37%
-0.06
Vorhandelsmarkt:
2.71
0.24
+9.72%
Schlusskurs vom Vortag:
$2.53
Offen:
$2.48
24-Stunden-Volumen:
51,095
Relative Volume:
1.74
Marktkapitalisierung:
$2.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.07M
KGV:
-0.4273
EPS:
-5.78
Netto-Cashflow:
$-7.34M
1W Leistung:
+6.01%
1M Leistung:
-53.98%
6M Leistung:
-73.77%
1J Leistung:
-87.41%
1-Tages-Spanne:
$2.38
$2.56
1-Wochen-Bereich:
$2.27
$2.66
52-Wochen-Spanne:
$2.27
$30.25
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Firmenname
Adial Pharmaceuticals Inc
Sektor
Branche
Telefon
434-422-9800
Adresse
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
2.47 | 2.81M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.81 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
756.76 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.07 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
314.36 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2018-10-30 | Eingeleitet | Maxim Group | Buy |
| 2018-10-11 | Eingeleitet | Dawson James | Buy |
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
Adial Pharmaceuticals Secures Exchange Listing Amid Regulatory Tailwinds - AD HOC NEWS
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Decreases By 87.7% - Defense World
ARMISTICE CAPITAL, LLC Acquires Shares in Adial Pharmaceuticals Inc - GuruFocus
Key facts: Adial Pharmaceuticals meets Nasdaq bid requirement; advances AD04 to Phase 3 trial - TradingView
Adial Pharmaceuticals Regains Nasdaq Compliance, Advances AD04 Program - TipRanks
Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement - Bitget
Adial Pharmaceuticals regains full compliance with Nasdaq listing requirement - marketscreener.com
Adial Regains Nasdaq Compliance as AD04 Advances, Engages in Partnering Talks - TradingView
Adial Pharmaceuticals Regains Full Compliance With Nasdaq Listing Requirement - TradingView
Adial Pharmaceuticals eyes single pivotal trial path for AD04 - Investing.com India
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One - Bitget
Adial Pharmaceuticals eyes single pivotal trial path for AD04 By Investing.com - Investing.com South Africa
Adial Pharmaceuticals stock rises on FDA policy shift - Investing.com
Adial Pharmaceuticals stock rises on FDA policy shift By Investing.com - Investing.com South Africa
Adial Pharmaceuticals (ADIL) Sees Potential in FDA's New Approva - GuruFocus
New FDA trial policy could speed addiction drug for heavy drinkers - Stock Titan
Portfolio Shifts: Can Adial Pharmaceuticals Inc outperform under higher oil pricesJuly 2025 Volume & Consistent Profit Alerts - baoquankhu1.vn
Alcohol Use Disorder Pipeline 2026: Latest FDA Approvals, Clinical Trials, And Emerging Therapies Assessment By Delveinsight Alkermes, Teva Pharma, Biocorrx, Inc., Adial Pharma, ADDEX THERAPEUTICS - Mena FN
Fund Flows: Whats the beta of Adial Pharmaceuticals Inc stockCPI Data & Technical Entry and Exit Alerts - baoquankhu1.vn
Adial Pharmaceuticals to Present at Oppenheimer Conference - Intellectia AI
Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Bitget
Litchfield Hills Research Estimates ADIL FY2025 Earnings - Defense World
ADIL Technical Analysis & ETF Price Forecast - Intellectia AI
Can Adial Pharmaceuticals Inc. outperform under higher oil pricesEarnings Growth Summary & Low Risk Entry Point Tips - mfd.ru
Buyback Watch: Whats the beta of Adial Pharmaceuticals Inc stockSell Signal & Community Consensus Picks - baoquankhu1.vn
Will Adial Pharmaceuticals Inc. stock benefit from commodity pricesJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - mfd.ru
Will Adial Pharmaceuticals Inc. benefit from geopolitical trends2025 Macro Impact & Growth Focused Entry Point Reports - mfd.ru
Market Leaders: Whats the fair value of Adial Pharmaceuticals Inc stockJuly 2025 Catalysts & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Why did Adial Pharmaceuticals stock plunge over 20% after hours today? - MSN
Why Is Adial Pharmaceuticals Stock (ADIL) Down Today? - TipRanks
Key facts: Adial Pharmaceuticals to execute reverse stock split; supports FDA trial - TradingView
Dow Jumps Over 200 Points; Uber Shares Fall After Q4 Results - Benzinga
Adial Pharmaceuticals Commends Congressional Directive for Alternative Clinical Trial Endpoints in Substance Use Disorder Treatments - Quiver Quantitative
Adial Pharma To Effect 1 For 25 Reverse Stock Split To Regain Nasdaq Compliance; Shares Plunge - Nasdaq
Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04 - marketscreener.com
Super Micro Computer Q2 Earnings Exceed Expectations - Intellectia AI
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Did Adial Pharmaceuticals Stock Plunge Over 20% After Hours Today? - Menafn.com
Adial Pharmaceuticals Applauds New Legislation for Addiction Treatment - Intellectia AI
U.S. Stocks Mixed; Eli Lilly Shares Surge After Earnings Beat - Intellectia AI
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split - Investing.com Nigeria
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split By Investing.com - Investing.com South Africa
Adial Pharmaceuticals (ADIL) Announces 1-for-25 Reverse Stock Sp - GuruFocus
Adial Pharmaceuticals announces 1-for-25 reverse stock split By Investing.com - Investing.com India
Adial Pharmaceuticals Announces Reverse Stock Split - citybiz
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement - The Manila Times
Adial Pharmaceuticals announces 1-for-25 reverse stock split - Investing.com
Adial Pharmaceuticals Announces Reverse Stock Split to - GlobeNewswire
Retail Trends: Is Adial Pharmaceuticals Inc affected by consumer sentimentStop Loss & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 24.9% in January - Defense World
Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.90%
2.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):